Download PDF
CC BY 4.0 · Indian J Med Paediatr Oncol 2023; 44(01): 138-148
DOI: 10.1055/s-0042-1759507
Review Article

Imaging Recommendations for Diagnosis, Staging, and Management of Pediatric Solid Tumors

Vasundhara Smriti
1   Department of Radiodiagnosis and Imaging, Homi Bhabha National Institute, Tata Memorial Hospital, Mumbai, Maharashtra, India
,
Akshay D. Baheti 
1   Department of Radiodiagnosis and Imaging, Homi Bhabha National Institute, Tata Memorial Hospital, Mumbai, Maharashtra, India
,
Sneha Shah
3   Department of Nuclear Medicine and molecular imaging, Homi Bhabha National Institute, Tata Memorial Hospital, Mumbai, Maharashtra, India
,
Sajid S. Qureshi 
4   Division of Pediatric Surgical Oncology, Department of Surgical Oncology, Homi Bhabha National Institute, Tata Memorial Hospital, Mumbai, Maharashtra, India
,
Nanadan Shetty
5   Department of Opthalmology, Homi Bhabha National Institute, Tata Memorial Hospital, Mumbai, Maharashtra, India
,
Kunal Gala 
2   Department of Intervention Radiology, Homi Bhabha National Institute, Tata Memorial Hospital, Mumbai, Maharashtra, India
,
Suyash Kulkarni
2   Department of Intervention Radiology, Homi Bhabha National Institute, Tata Memorial Hospital, Mumbai, Maharashtra, India
,
Abhijit Raut
6   Department of Radiodiagnosis, Kokilaben Dhirubhai Ambani Hospital, Mumbai, Maharashtra, India
,
Veenita Kamble
6   Department of Radiodiagnosis, Kokilaben Dhirubhai Ambani Hospital, Mumbai, Maharashtra, India
,
Girish Chinnaswamy
7   Department of Pediatric Oncology, Homi Bhabha National Institute, Tata Memorial Hospital, Mumbai, Maharashtra, India
,
Maya Prasad 
7   Department of Pediatric Oncology, Homi Bhabha National Institute, Tata Memorial Hospital, Mumbai, Maharashtra, India
,
Badira C. P
7   Department of Pediatric Oncology, Homi Bhabha National Institute, Tata Memorial Hospital, Mumbai, Maharashtra, India
,
Mukta Ramadwar
8   Department of Pathology, Homi Bhabha National Institute, Tata Memorial Hospital, Mumbai, Maharashtra, India
,
Suryaveer Singh 
1   Department of Radiodiagnosis and Imaging, Homi Bhabha National Institute, Tata Memorial Hospital, Mumbai, Maharashtra, India
,
Anuradha Shukla
1   Department of Radiodiagnosis and Imaging, Homi Bhabha National Institute, Tata Memorial Hospital, Mumbai, Maharashtra, India
,
Hirenkumar Panwala 
9   Department of Radiodiagnosis, SRCC Children's Hospital, Mumbai, Maharashtra, India
,
Arpita Sahu
1   Department of Radiodiagnosis and Imaging, Homi Bhabha National Institute, Tata Memorial Hospital, Mumbai, Maharashtra, India
,
Laskar Siddharth
10   Department of Radiation Oncology, Homi Bhabha National Institute, Tata Memorial Hospital, Mumbai, Maharashtra, India
,
Tejas Kapadia 
11   Children's X-ray Department/Academic Unit of Paediatric Radiology, Royal Manchester Children's Hospital, Manchester, United Kingdom
› Author Affiliations
› Further Information
   Permissions and Reprints

Abstract

Paediatric extra-cranial solid tumours are one of the common causes for paediatric malignancies. Lack of appropriate imaging at presentation, staging and for follow-up is a major challenge for paediatric solid tumours. We have reviewed the paediatric solid tumour imaging protocols suggested by the major oncological societies/groups around the world (mainly the SIOP – Society International Pediatric Oncology, and the COG – Children's Oncology Group). We have adapted some of those protocols to develop imaging recommendations for the diagnosis, staging and management of extra-cranial solid tumours based on the treatment protocols followed in India.

Keywords

hepatoblastoma - imaging guidelines - neuroblastoma - pediatric oncology - pediatric solid tumors - Wilm's tumor

Note

The article is not under consideration for publication elsewhere. Each author participated sufficiently for the work to be submitted. Publication is approved by all authors.


Supplementary Material



Publication History

Article published online:
06 March 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Bhakta N, Force LM, Allemani C. et al. Childhood cancer burden: a review of global estimates. Lancet Oncol 2019; 20 (01) e42-e53
    CrossrefPubMedGoogle Scholar
  • 2 Johnston WT, Erdmann F, Newton R, Steliarova-Foucher E, Schüz J, Roman E. Childhood cancer: Estimating regional and global incidence. Cancer Epidemiol 2021; 71 (Pt B): 101662
    CrossrefPubMedGoogle Scholar
  • 3 Kushner BH, Khakoo Y. Enigmatic entities: opsoclonus myoclonus ataxia syndrome linked to neuroblastoma. Lancet Child Adolesc Health 2018; 2 (01) 3-5
    CrossrefPubMedGoogle Scholar
  • 4 Maas MH, Cransberg K, van Grotel M, Pieters R, van den Heuvel-Eibrink MM. Renin-induced hypertension in Wilms tumor patients. Pediatr Blood Cancer 2007; 48 (05) 500-503
    CrossrefPubMedGoogle Scholar
  • 5 Yhoshu E, Lone YA, Mahajan JK, Singh UB. Hepatoblastoma with precocious puberty. J Indian Assoc Pediatr Surg 2019; 24 (01) 68-71
    CrossrefPubMedGoogle Scholar
  • 6 Schooler GR, Squires JH, Alazraki A. et al. Pediatric hepatoblastoma, hepatocellular carcinoma, and other hepatic neoplasms: Consensus Imaging Recommendations from American College of Radiology Pediatric Liver Reporting and Data System (LI-RADS) Working Group. Radiology 2020; 296 (03) 493-497
    CrossrefPubMedGoogle Scholar
  • 7 Callahan MJ, Cravero JP. Should I irradiate with computed tomography or sedate for magnetic resonance imaging?. Pediatr Radiol 2022; 52 (02) 340-344
    CrossrefPubMedGoogle Scholar
  • 8 Ng K, Mogul DB. Pediatric liver tumors. Clin Liver Dis 2018; 22 (04) 753-772
    CrossrefPubMedGoogle Scholar
  • 9 Czauderna P, Lopez-Terrada D, Hiyama E, Häberle B, Malogolowkin MH, Meyers RL. Hepatoblastoma state of the art: pathology, genetics, risk stratification, and chemotherapy. Curr Opin Pediatr 2014; 26 (01) 19-28
    CrossrefPubMedGoogle Scholar
  • 10 Spector LG, Birch J. The epidemiology of hepatoblastoma. Pediatr Blood Cancer 2012; 59 (05) 776-779
    CrossrefPubMedGoogle Scholar
  • 11 Towbin AJ, Meyers RL, Woodley H. et al. 2017 PRETEXT: radiologic staging system for primary hepatic malignancies of childhood revised for the Paediatric Hepatic International Tumour Trial (PHITT). Pediatr Radiol 2018; 48 (04) 536-554
    CrossrefPubMedGoogle Scholar
  • 12 Agarwala S, Gupta A, Bansal D. et al. Management of hepatoblastoma: ICMR consensus document. Indian J Pediatr 2017; 84 (06) 456-464
    CrossrefPubMedGoogle Scholar
  • 13 Cunningham ME, Klug TD, Nuchtern JG. et al. Global disparities in Wilms tumor. J Surg Res 2020; 247: 34-51
    CrossrefPubMedGoogle Scholar
  • 14 Charlton J, Irtan S, Bergeron C, Pritchard-Jones K. Bilateral Wilms tumour: a review of clinical and molecular features. Expert Rev Mol Med 2017; 19: e8
    CrossrefPubMedGoogle Scholar
  • 15 Nelson MV, van den Heuvel-Eibrink MM, Graf N, Dome JS. New approaches to risk stratification for Wilms tumor. Curr Opin Pediatr 2021; 33 (01) 40-48
    CrossrefPubMedGoogle Scholar
  • 16 Qureshi SS, Kembhavi SA, Bhagat M. et al. Customized approach for upfront or delayed resection using radiological criteria in unilateral, nonmetastatic pediatric renal tumors: a prospective study. Pediatr Blood Cancer 2019; 66 (Suppl. 03) e27815
    CrossrefPubMedGoogle Scholar
  • 17 Qureshi SS, Bhagat M, Kazi M. et al. Standardizing lymph nodal sampling for Wilms tumor: a feasibility study with outcomes. J Pediatr Surg 2020; 55 (12) 2668-2675
    CrossrefPubMedGoogle Scholar
  • 18 Qureshi SS, Bhagat M, Smriti V. et al. Intravascular extension of Wilms tumor: Characteristics of tumor thrombus and their impact on outcomes. J Pediatr Urol 2021; 17 (01) 69.e1-69.e8
    CrossrefPubMedGoogle Scholar
  • 19 NCG guidelines. 2020. Paediatric hematolymphoid and solid tumours. Accessed November 07, 2022, at: https://tmc.gov.in/ncg/index.php/107-guidlines
  • 20 Kembhavi SA, Qureshi S, Vora T. et al. Understanding the principles in management of Wilms' tumour: can imaging assist in patient selection?. Clin Radiol 2013; 68 (07) 646-653
    CrossrefPubMedGoogle Scholar
  • 21 Prasad M, Vora T, Agarwala S. et al. Management of Wilms tumor: ICMR consensus document. Indian J Pediatr 2017; 84 (06) 437-445
    CrossrefPubMedGoogle Scholar
  • 22 Shaikh F, Murray MJ, Amatruda JF. et al. Paediatric extracranial germ-cell tumours. Lancet Oncol 2016; 17 (04) e149-e162
    CrossrefPubMedGoogle Scholar
  • 23 Faure-Conter C, Rocourt N, Sudour-Bonnange H. et al. [Pediatric germ cell tumours]. Bull Cancer 2013; 100 (04) 381-391
    PubMedGoogle Scholar
  • 24 Horton Z, Schlatter M, Schultz S. Pediatric germ cell tumors. Surg Oncol 2007; 16 (03) 205-213
    CrossrefPubMedGoogle Scholar
  • 25 Agarwala S, Mitra A, Bansal D. et al. Management of pediatric malignant germ cell tumors: ICMR consensus document. Indian J Pediatr 2017; 84 (06) 465-472
    CrossrefPubMedGoogle Scholar
  • 26 Dieckmann KP, Frey U, Lock G. Contemporary diagnostic work-up of testicular germ cell tumours. Nat Rev Urol 2013; 10 (12) 703-712
    CrossrefPubMedGoogle Scholar
  • 27 Feldman DR. State-of-the-art management of germ cell tumors. Am Soc Clin Oncol Educ Book 2018; 38 (38) 319-323
    CrossrefPubMedGoogle Scholar
  • 28 Matthay KK, Shulkin B, Ladenstein R. et al. Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force. Br J Cancer 2010; 102 (09) 1319-1326
    CrossrefPubMedGoogle Scholar
  • 29 Monclair T, Brodeur GM, Ambros PF. et al; INRG Task Force. The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report. J Clin Oncol 2009; 27 (02) 298-303
    CrossrefPubMedGoogle Scholar
  • 30 Kembhavi SA, Shah S, Rangarajan V, Qureshi S, Popat P, Kurkure P. Imaging in neuroblastoma: An update. Indian J Radiol Imaging 2015; 25 (02) 129-136
    Article in Thieme ConnectPubMedGoogle Scholar
  • 31 Sharp SE, Shulkin BL, Gelfand MJ, Salisbury S, Furman WL. 123I-MIBG scintigraphy and 18F-FDG PET in neuroblastoma. J Nucl Med 2009; 50 (08) 1237-1243
    CrossrefPubMedGoogle Scholar
  • 32 Ward E, DeSantis C, Robbins A, Kohler B, Jemal A. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin 2014; 64 (02) 83-103
    CrossrefPubMedGoogle Scholar
  • 33 Ripperger T, Bielack SS, Borkhardt A. et al. Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology. Am J Med Genet A 2017; 173 (04) 1017-1037
    CrossrefPubMedGoogle Scholar
  • 34 Skapek SX, Ferrari A, Gupta AA. et al. Rhabdomyosarcoma. Nat Rev Dis Primers 2019; 5 (01) 1
    CrossrefPubMedGoogle Scholar
  • 35 Arndt CAS, Bisogno G, Koscielniak E. Fifty years of rhabdomyosarcoma studies on both sides of the pond and lessons learned. Cancer Treat Rev 2018; 68: 94-101
    CrossrefPubMedGoogle Scholar
  • 36 Hibbitts E, Chi YY, Hawkins DS. et al. Refinement of risk stratification for childhood rhabdomyosarcoma using FOXO1 fusion status in addition to established clinical outcome predictors: a report from the Children's Oncology Group. Cancer Med 2019; 8 (14) 6437-6448
    CrossrefPubMedGoogle Scholar
  • 37 van Ewijk R, Schoot RA, Sparber-Sauer M. et al; Cooperative Weichteilsarkom Studiengruppe Imaging Group, the European Society of Paediatric Radiology Oncology Task Force and the European Paediatric Soft Tissue Sarcoma Study Group Imaging Committee. European guideline for imaging in paediatric and adolescent rhabdomyosarcoma - joint statement by the European Paediatric Soft Tissue Sarcoma Study Group, the Cooperative Weichteilsarkom Studiengruppe and the Oncology Task Force of the European Society of Paediatric Radiology. Pediatr Radiol 2021; 51 (10) 1940-1951
    CrossrefPubMedGoogle Scholar
  • 38 O JH, Lodge MA, Wahl RL. O JH. Practical PERCIST: a simplified guide to PET response criteria in solid tumors 1.0. Radiology 2016; 280 (02) 576-584
    CrossrefPubMedGoogle Scholar
  • 39 Accessed November 07, 2022, at: https://tmc.gov.in/tmh/pdf/EBM%202018-Guidelines%20for%20Paediatric%20Solid%20Tumours.pdf
  • 40 Crist WM, Anderson JR, Meza JL. et al. Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease. J Clin Oncol 2001; 19 (12) 3091-3102
    CrossrefPubMedGoogle Scholar
  • 41 Raney RB, Walterhouse DO, Meza JL. et al. Results of the Intergroup Rhabdomyosarcoma Study Group D9602 protocol, using vincristine and dactinomycin with or without cyclophosphamide and radiation therapy, for newly diagnosed patients with low-risk embryonal rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. J Clin Oncol 2011; 29 (10) 1312-1318
    CrossrefPubMedGoogle Scholar
  • 42 Kivelä T. The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death. Br J Ophthalmol 2009; 93 (09) 1129-1131
    CrossrefPubMedGoogle Scholar
  • 43 Rodriguez-Galindo C, Orbach DB, VanderVeen D. Retinoblastoma. Pediatr Clin North Am 2015; 62 (01) 201-223
    CrossrefPubMedGoogle Scholar
  • 44 Rangamani S, SathishKumar K, Manoharan N. et al. Paediatric retinoblastoma in India: evidence from the National Cancer Registry Programme. Asian Pac J Cancer Prev 2015; 16 (10) 4193-4198
    CrossrefPubMedGoogle Scholar
  • 45 Stathopoulos C, Lumbroso-Le Rouic L, Moll AC. et al. Current indications of secondary enucleation in retinoblastoma management: a position paper on behalf of the European Retinoblastoma Group (EURbG). Cancers (Basel) 2021; 13 (14) 3392
    CrossrefPubMedGoogle Scholar